Detalhe da pesquisa
1.
Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer.
BMC Cancer
; 16(1): 814, 2016 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27765027
2.
In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma.
Gynecol Oncol
; 143(2): 379-388, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27614696
3.
Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting.
Sci Rep
; 11(1): 8076, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33850213
4.
Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance.
NAR Cancer
; 3(3): zcab028, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34316715
5.
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.
J Natl Cancer Inst
; 110(10): 1123-1132, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29788332
6.
Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts.
Neoplasia
; 19(8): 628-636, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28658648
7.
Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer.
PLoS One
; 11(3): e0150564, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26991655
8.
A novel neutralizing antibody targeting pregnancy-associated plasma protein-a inhibits ovarian cancer growth and ascites accumulation in patient mouse tumorgrafts.
Mol Cancer Ther
; 14(4): 973-81, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25695953
9.
Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft.
PLoS One
; 10(5): e0126867, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25962155
10.
Tumorgrafts as in vivo surrogates for women with ovarian cancer.
Clin Cancer Res
; 20(5): 1288-97, 2014 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24398046
11.
Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment.
Front Oncol
; 3: 295, 2013 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24363999
12.
Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth.
Mol Cancer Ther
; 12(12): 2909-16, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24130056
13.
IGFBP ratio confers resistance to IGF targeting and correlates with increased invasion and poor outcome in breast tumors.
Clin Cancer Res
; 18(6): 1808-17, 2012 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22287600
14.
The IGF pathway regulates ERα through a S6K1-dependent mechanism in breast cancer cells.
Mol Endocrinol
; 25(3): 516-28, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21292829